These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2538007)

  • 1. Determination and metabolism of dithiol chelating agents. VI. Isolation and identification of the mixed disulfides of meso-2,3-dimercaptosuccinic acid with L-cysteine in human urine.
    Maiorino RM; Bruce DC; Aposhian HV
    Toxicol Appl Pharmacol; 1989 Feb; 97(2):338-49. PubMed ID: 2538007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation.
    Maiorino RM; Akins JM; Blaha K; Carter DE; Aposhian HV
    J Pharmacol Exp Ther; 1990 Aug; 254(2):570-7. PubMed ID: 2166796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination and metabolism of dithiol chelating agents. XV. The meso-2,3-dimercaptosuccinic acid-cysteine (1:2) mixed disulfide, a major urinary metabolite of DMSA in the human, increases the urinary excretion of lead in the rat.
    Maiorino RM; Aposhian MM; Xu ZF; Li Y; Polt RL; Aposhian HV
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1221-6. PubMed ID: 8263783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. meso-2,3-Dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent.
    Aposhian HV; Aposhian MM
    Annu Rev Pharmacol Toxicol; 1990; 30():279-306. PubMed ID: 2160791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination and metabolism of dithiol chelating agents. IV. Urinary excretion of meso-2,3-dimercaptosuccinic acid and mercaptosuccinic acid in rabbits given meso-2,3-dimercaptosuccinic acid.
    Maiorino RM; Aposhian HV
    Biochem Pharmacol; 1989 Apr; 38(7):1147-54. PubMed ID: 2539817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of meso-2,3-dimercaptosuccinic acid in human subjects.
    Aposhian HV; Maiorino RM; Dart RC; Perry DF
    Clin Pharmacol Ther; 1989 May; 45(5):520-6. PubMed ID: 2541962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination and metabolism of dithiol chelating agents. III. Formation of oxidized metabolites of 2,3-dimercaptopropane-1-sulfonic acid in rabbit.
    Maiorino RM; Weber GL; Aposhian HV
    Drug Metab Dispos; 1988; 16(3):455-63. PubMed ID: 2900740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination and metabolism of dithiol chelating agents. XVII. In humans, sodium 2,3-dimercapto-1-propanesulfonate is bound to plasma albumin via mixed disulfide formation and is found in the urine as cyclic polymeric disulfides.
    Maiorino RM; Xu ZF; Aposhian HV
    J Pharmacol Exp Ther; 1996 Apr; 277(1):375-84. PubMed ID: 8613944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of meso-2,3-dimercaptosuccinic acid in lead-poisoned children and normal adults.
    Asiedu P; Moulton T; Blum CB; Roldan E; Lolacono NJ; Graziano JH
    Environ Health Perspect; 1995; 103(7-8):734-9. PubMed ID: 7588486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination and metabolism of dithiol chelating agents. VIII. Metal complexes of meso-dimercaptosuccinic acid.
    Rivera M; Zheng W; Aposhian HV; Fernando Q
    Toxicol Appl Pharmacol; 1989 Aug; 100(1):96-106. PubMed ID: 2548305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobilization of heavy metals by newer, therapeutically useful chelating agents.
    Aposhian HV; Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Dart RC; Aposhian MM
    Toxicology; 1995 Mar; 97(1-3):23-38. PubMed ID: 7716789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination and metabolism of dithiol-chelating agents: electrolytic and chemical reduction of oxidized dithiols in urine.
    Maiorino RM; Barry TJ; Aposhian HV
    Anal Biochem; 1987 Jan; 160(1):217-26. PubMed ID: 3032019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of lead decreases the availability of meso-2, 3-dimercaptosuccinic acid for analysis in the monobromobimane assay.
    Lever SZ; Parsons TL
    Chem Res Toxicol; 1999 Nov; 12(11):1057-65. PubMed ID: 10563831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination and metabolism of dithiol chelating agents. VII. Biliary excretion of dithiols and their interactions with cadmium and metallothionein.
    Zheng W; Maiorino RM; Brendel K; Aposhian HV
    Fundam Appl Toxicol; 1990 Apr; 14(3):598-607. PubMed ID: 2160390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of a lead mobilization test using the chelating agent dimercaptosuccinic acid.
    Hoet P; Buchet JP; Decerf L; Lavalleye B; Haufroid V; Lison D
    Clin Chem; 2006 Jan; 52(1):88-96. PubMed ID: 16239340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of meso-2,3-dimercaptosuccinic acid in human urine by capillary electrophoresis using direct injection.
    Zhu X; Lever SZ
    Anal Bioanal Chem; 2003 Oct; 377(4):666-9. PubMed ID: 12904952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimercaptan metal-binding agents influence the biotransformation of arsenite in the rabbit.
    Maiorino RM; Aposhian HV
    Toxicol Appl Pharmacol; 1985 Feb; 77(2):240-50. PubMed ID: 2983455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of gallium arsenide-induced suppression of the antibody response by a mixed disulfide metabolite of meso-2,3-dimercaptosuccinic acid.
    Burns LA; Butterworth LF; Munson AE
    J Pharmacol Exp Ther; 1993 Feb; 264(2):695-700. PubMed ID: 8382280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.